GlassScriptPhysician profile
Priscilla L Lawrence
NPI 1699724641
$921.04
in general payments reported to CMS, 2019-2025
16 companies · $542 in 2025
The $542 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2023: $113 · 2024: $103 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559 · Long Term Medical Supply Or Device Loan: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.04 |
| Long Term Medical Supply Or Device Loan | $199.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $204.94 | 2025 | |
| Abbott Laboratories | $192.79 | 2021-2024 | Ensite Precision, Esprit, Mitraclip |
| Janssen Biotech, INC. | $80.66 | 2021-2025 | Rybrevant, Erleada, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $77.83 | 2024-2025 | Enhertu |
| Caris Mpi, INC. | $58.42 | 2025 | Mi Cancer Seek |
| Astellas Pharma US INC | $48.48 | 2023 | Xtandi |
| Kestra Medical Technology Services, INC. | $48.23 | 2023-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $35.84 | 2025 | Opdivo |
| Pfizer INC. | $29.68 | 2024-2025 | |
| Gilead Sciences, INC. | $29.08 | 2021-2025 | Trodelvy |
| Incyte Corporation | $25.59 | 2025 | Jakafi |
| Daiichi Sankyo INC. | $24.92 | 2025 | Enhertu |
| Merck Sharp & Dohme LLC | $19.56 | 2025 | |
| Genzyme Corporation | $19.35 | 2025 | |
| Puma Biotechnology, INC. | $18.75 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $6.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.